Dublin, Ireland-based Covidien has acquired Irvine, Calif.-based Reverse Medical Corp.
Reverse Medical is a medical device company focused on vascular disease management. Through the acquisition, Covidien will expand its existing portfolio to include vascular technologies to help the company compete in the worldwide vascular embolization market, according to a news release.
Financial terms of the acquisition were not disclosed.
In June, Medtronic entered a definitive agreement to acquire Covidien for $42.9 billion.
More articles on acquisitions:
Roche to buy InterMune for $8.3B
Duke LifePoint, Conemaugh Health reach definitive acquisition agreement
5 recent hospital transactions and partnerships